Company Description
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
The company offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services.
It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces.
In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards.
The company was founded in 1979 and is based in Addison, Texas. Concentra Group Holdings Parent, Inc. was formerly a subsidiary of Select Medical Corporation.
| Country | United States |
| Founded | 1979 |
| IPO Date | Jul 25, 2024 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 8,856 |
| CEO | William Newton |
Contact Details
Address: 5080 Spectrum Drive, Suite 1200W Addison, Texas 75001 United States | |
| Phone | 972-364-8000 |
| Website | concentra.com |
Stock Details
| Ticker Symbol | CON |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $23.50 |
| CIK Code | 0002014596 |
| CUSIP Number | 20603L102 |
| ISIN Number | US20603L1026 |
| Employer ID | 30-1006613 |
| SIC Code | 8093 |
Key Executives
| Name | Position |
|---|---|
| William Keith Newton | Chief Executive Officer and Director |
| Matthew T. DiCanio M.B.A., MBA | President and Chief Financial Officer |
| Su Zan Nelson CPA, CPA | Executive Vice President and Chief Accounting Officer |
| John A. deLorimier | Executive Vice President and Chief Information and Technology Officer |
| Dr. John R. Anderson DO, FACOEM | Executive Vice President and Chief Medical Officer |
| Michael A. Kosuth | Executive Vice President and Chief Operating Officer of East |
| Timothy F. Ryan | Executive Vice President and Chief Legal Counsel |
| Thomas A. Devasia | Executive Vice President and Chief Marketing and Innovation Officer |
| Danielle Kendall | Executive Vice President and Chief People Officer |
| Giovanni Gallara | Executive Vice President and Chief Clinical Services Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 21, 2025 | 8-K | Current Report |
| Apr 21, 2025 | SCHEDULE 13G/A | Filing |
| Apr 15, 2025 | SCHEDULE 13G | Filing |
| Mar 18, 2025 | ARS | Filing |
| Mar 18, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 18, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 4, 2025 | SCHEDULE 13D/A | Filing |
| Mar 4, 2025 | SCHEDULE 13D/A | Filing |
| Mar 3, 2025 | 10-K | Annual Report |
| Mar 3, 2025 | 8-K | Current Report |